Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

TCT 2023: Medtronic adds to the body of evidence for Evolut TAVR with late-breaking clinical trial data from the Evolut Low Risk Trial

News | TCT

Medtronic Evolut TAVR Platform Outperforms Surgery with Sustained Valve Performance for Low-risk Patients at Four Years

October 25, 2023 — Medtronic plc, a global leader in healthcare technology, announced four-year results from the Evolut ...

October 25, 2023

Edwards Lifesciences announced new data from the PARTNER 3 trial demonstrating continued low rates of all-cause mortality, disabling stroke and rehospitalization at five years

News | Cardiovascular Surgery

Five-year Data from Partner 3 Trial Demonstrate Excellent Survival for Patients Receiving Edwards Sapien 3 Valve

October 25, 2023 — Edwards Lifesciences announced new data from the PARTNER 3 trial demonstrating continued low rates of ...

October 25, 2023

Analysis is first to compare health system-based electronic health record data for treatment of pulmonary embolism with interventional devices

News | Pulmonary Embolism

REAL-PE Study Demonstrates Statistically Significant Lower Major Bleeding Rates with the EKOS Endovascular System Compared to Mechanical Thrombectomy Device for Treatment of Pulmonary Embolism

October 25, 2023 — Data from the REAL-PE study was presented today at Transcatheter Cardiovascular Therapeutics(TCT) ...

October 25, 2023

Clinical research validates utility of IVL in complex nodular and eccentric calcium

News | Cath Lab

New Shockwave Coronary IVL Publications Confirm Safety and Efficacy Across Multiple Calcium Morphologies

October 25, 2023 — Shockwave Medical, Inc., a pioneer in the development and commercialization of transformational ...

October 25, 2023

WATCH TAVR trial presented at the Transcatheter Cardiovascular Therapeutics annual conference

News | Left Atrial Appendage (LAA) Occluders

Cleveland Clinic-Led Trial Finds that Atrial Fibrillation Patients Undergoing TAVR and Watchman Procedures Together Have Similar Outcomes to Using Blood Thinners after TAVR

October 25, 2023 — Findings from a trial led by Cleveland Clinic show that patients with atrial fibrillation undergoing ...

October 25, 2023

3-part video series on hypertrophic cardiomyopathy with Christine E. Seidman, MD, FACC, FAHA

Feature | Pharmaceuticals | By Christine Book

Hypertrophic Cardiomyopathy Video Series with Christine E. Seidman, MD, FACC, FAHA

In a new 3-part video series on hypertrophic cardiomyopathy with Christine E. Seidman, MD, FACC, FAHA, Managing Editor ...

October 25, 2023

News | Implantable Cardioverter Defibrillator (ICD)

Medtronic Receives FDA Approval for Extravascular Defibrillator to Treat Abnormal Heart Rhythms, Sudden Cardiac Arrest

October 23, 2023 — Medtronic plc, a global leader in healthcare technology, has received U.S. Food and Drug ...

October 23, 2023

The ALIGN-AR trial is a landmark prospective, single-arm investigation device exemption (IDE) study designed to assess the safety and efficacy of the Trilogy THV System

News | Cardiovascular Clinical Studies

JenaValve Announces ALIGN-AR Pivotal Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2023

October 20, 2023 — JenaValve Technology, Inc., developer and manufacturer of the Trilogy Transcatheter Heart Valve (THV) ...

October 20, 2023

Published late-breaking clinical data presented at TCT 2023

News | Heart Failure

Gene Discoveries Could Help Prevent Deadly Coronary Artery Disease

October 20, 2023 — An international team of scientists has identified nearly a dozen genes that contribute to calcium ...

October 20, 2023

Late-breaking trials will be presented during the main sessions and highlighted during press conferences scheduled for Oct. 24, 25 and 26

Feature | TCT | By Melinda Taschetta-Millane

TCT23 Late-breakers: Full Schedule Announced

Innovation. Connection. Inspiration. The Transcatheter Cardiovascular Therapeutics (TCT) 2023 conference, the Cardiovas ...

October 20, 2023

The CLAAS System to be highlighted daily at TCT, including a live case presentation by Dr. Shephal Doshi

News | Left Atrial Appendage (LAA) Occluders

Conformal Medical to Present One-Year Data from its Left Atrial Appendage Occlusion (LAAO) Early Feasibility Study at TCT 2023

October 19, 2023 — Conformal Medical, Inc. announced today the one-year results from the company's CONFORMAL Early ...

October 19, 2023

News | TCT

Results of SAFE-TAVI Clinical Study Anticipated at TCT 2023

October 19, 2023 — OpSens, a medical device cardiology-focused company, has announced that results of the “SAFE-TAVI ...

October 19, 2023

Cardiovascular Research Foundation's (CRF) annual scientific symposium, Transcatheter Cardiovascular Therapeutics, TCT 2023, is set for October 23-26 in San Francisco

Feature | TCT | Christine Book

TCT 2023 Leadership Anticipates 'Practice Changing' Findings Ahead of 35th Scientific Symposium

October 18, 2023 — The following is an updated program preview of the Cardiovascular Research Foundation's (CRF) annual ...

October 18, 2023

Study in low-risk patients reveals 5-year survival rate of 93%

News | Cardiovascular Surgery

Largest US Cardiac Database Shows Excellent Long-term Survival After Surgical Aortic Valve Replacement

October 18, 2023 — A study published in The Annals of Thoracic Surgery demonstrates outstanding long-term survival ...

October 18, 2023

News | Cardiovascular Surgery

Walgreens and the Cardiovascular Research Foundation Unite to Improve Recognition and Diagnosis of Valvular Heart Disease for Older Americans

October 18, 2023 — Walgreens and the Cardiovascular Research Foundation (CRF) announced a collaboration to drive forward ...

October 18, 2023